# The Oral cGVHD as a Predictive Factor of Graft Versus Leukaemia Effect in Patients Who Received an Allograft

> **NCT07271498** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nice** · enrollment: 93 (actual)

## Conditions studied

- Allografts
- Oral cGVHD

## Interventions

- **OTHER:** Evaluation of oral cGVHD

## Key facts

- **NCT ID:** NCT07271498
- **Lead sponsor:** Centre Hospitalier Universitaire de Nice
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07271498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07271498, "The Oral cGVHD as a Predictive Factor of Graft Versus Leukaemia Effect in Patients Who Received an Allograft". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07271498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*